Literature DB >> 27876152

The Role of Substance P in Pulmonary Clearance of Bacteria in Comparative Injury Models.

Terry Hsieh1, Max H Vaickus1, Thor D Stein2, Bethany L Lussier1, Jiyoun Kim1, David M Stepien1, Elizabeth R Duffy1, Evan L Chiswick1, Daniel G Remick3.   

Abstract

Neural input to the immune system can alter its ability to clear pathogens effectively. Patients suffering mild traumatic brain injury (mTBI) have shown reduced rates of pneumonia and a murine model replicated these findings, with better overall survival of TBI mice compared with sham-injured mice. To further investigate the mechanism of improved host response in TBI mice, this study developed and characterized a mild tail trauma model of similar severity to mild TBI. Both mild tail trauma and TBI induced similar systemic changes that normalized within 48 hours, including release of substance P. Examination of tissues showed that injuries are limited to the target tissue (ie, tail in tail trauma, brain in mTBI). Pneumonia challenge showed that mild TBI mice showed improved immune responses, characterized by the following: i) increased survival, ii) increased pulmonary neutrophil recruitment, iii) increased bacterial clearance, and iv) increased phagocytic cell killing of bacteria compared with tail trauma. Administration of a neurokinin-1-receptor antagonist to block substance P signaling eliminated the improved survival of mTBI mice. Neurokinin-1-receptor antagonism did not alter pneumonia mortality in tail trauma mice. These data show that immune benefits of trauma are specific to mTBI and that tail trauma is an appropriate control for future studies aimed at elucidating the mechanisms of improved innate immune responses in mTBI mice.
Copyright © 2016 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27876152      PMCID: PMC5225288          DOI: 10.1016/j.ajpath.2016.08.014

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  29 in total

1.  Assessing pulmonary pathology by detailed examination of respiratory function.

Authors:  Louis J Vaickus; Jacqueline Bouchard; Jiyoun Kim; Sudha Natarajan; Daniel G Remick
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

Review 2.  Neurokinin-1 receptor: functional significance in the immune system in reference to selected infections and inflammation.

Authors:  Steven D Douglas; Susan E Leeman
Journal:  Ann N Y Acad Sci       Date:  2010-11-22       Impact factor: 5.691

3.  Enhancement of phagocytosis - a newly found activity of substance P residing in its N-terminal tetrapeptide sequence.

Authors:  Z Bar-Shavit; R Goldman; Y Stabinsky; P Gottlieb; M Fridkin; V I Teichberg; S Blumberg
Journal:  Biochem Biophys Res Commun       Date:  1980-06-30       Impact factor: 3.575

4.  Substance P primes the formation of hydrogen peroxide and nitric oxide in human neutrophils.

Authors:  A Sterner-Kock; R K Braun; A van der Vliet; M D Schrenzel; R J McDonald; M B Kabbur; P R Vulliet; D M Hyde
Journal:  J Leukoc Biol       Date:  1999-06       Impact factor: 4.962

5.  Eotaxin represents the principal eosinophil chemoattractant in a novel murine asthma model induced by house dust containing cockroach allergens.

Authors:  J Kim; A C Merry; J A Nemzek; G L Bolgos; J Siddiqui; D G Remick
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

6.  Evans Blue Dye as an in vivo marker of myofibre damage: optimising parameters for detecting initial myofibre membrane permeability.

Authors:  P W Hamer; J M McGeachie; M J Davies; M D Grounds
Journal:  J Anat       Date:  2002-01       Impact factor: 2.610

7.  Reduced expression of virulence factors in multidrug-resistant Pseudomonas aeruginosa strains.

Authors:  Aleksander Deptuła; Eugenia Gospodarek
Journal:  Arch Microbiol       Date:  2009-12-04       Impact factor: 2.552

8.  Substance P mediates reduced pneumonia rates after traumatic brain injury.

Authors:  Sung Yang; David Stepien; Dennis Hanseman; Bryce Robinson; Michael D Goodman; Timothy A Pritts; Charles C Caldwell; Daniel G Remick; Alex B Lentsch
Journal:  Crit Care Med       Date:  2014-09       Impact factor: 7.598

9.  Serum substance P levels are associated with severity and mortality in patients with severe traumatic brain injury.

Authors:  Leonardo Lorente; María M Martín; Teresa Almeida; Mariano Hernández; Luis Ramos; Mónica Argueso; Juan J Cáceres; Jordi Solé-Violán; Alejandro Jiménez
Journal:  Crit Care       Date:  2015-04-27       Impact factor: 9.097

Review 10.  Traumatic Brain Injury and Peripheral Immune Suppression: Primer and Prospectus.

Authors:  Jon Hazeldine; Janet M Lord; Antonio Belli
Journal:  Front Neurol       Date:  2015-11-05       Impact factor: 4.003

View more
  3 in total

1.  Mild Traumatic Brain Injury in Mice Beneficially Alters Lung NK1R and Structural Protein Expression to Enhance Survival after Pseudomonas aeruginosa Infection.

Authors:  Max Vaickus; Terry Hsieh; Ekaterina Kintsurashvili; Jiyoun Kim; Daniel Kirsch; George Kasotakis; Daniel G Remick
Journal:  Am J Pathol       Date:  2018-11-23       Impact factor: 4.307

Review 2.  Mammalian Neuropeptides as Modulators of Microbial Infections: Their Dual Role in Defense versus Virulence and Pathogenesis.

Authors:  Daria Augustyniak; Eliza Kramarska; Paweł Mackiewicz; Magdalena Orczyk-Pawiłowicz; Fionnuala T Lundy
Journal:  Int J Mol Sci       Date:  2021-04-01       Impact factor: 5.923

3.  Estrogen Alleviates Sex-Dependent Differences in Lung Bacterial Clearance and Mortality Secondary to Bacterial Pneumonia after Traumatic Brain Injury.

Authors:  Jean-Francois Pittet; Parker J Hu; Jaideep Honavar; Angela P Brandon; Cilina A Evans; Rebekah Muthalaly; Qiang Ding; Brant M Wagener
Journal:  J Neurotrauma       Date:  2020-12-29       Impact factor: 5.269

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.